AC Immune acquires Parkinson’s disease vaccine candidate

28th July 2021 Uncategorised 0

AC Immune is set to acquire Affiris’ entire portfolio of therapeutics targeting alpha-synuclein

More: AC Immune acquires Parkinson’s disease vaccine candidate
Source: News